You are here

A piece of news

First neuroregeneration clinical trials in humans to treat spinal-cord injuries

Previous experiments with animal models have recovered functions lost after a neurological injury.

AddToAny buttons: 

By Biocat

The central nervous system’s limited capacity for self-repair after neurological injury, which can lead to loss of mobility or speech among other things, is the main cause that leads these conditions to become chronic. For many years, these injuries were thought to be irreversible. However in the nineties, it was shown that neurons have the ability to regenerate in vitro. Afterwards, scientists also showed that this capacity persists in vivo.

At the scientific debates Neuroregeneration: Is It the common frontier for Bioengineering, Neuroscience, Robotics and Neurorehabilitation? held by B·Debate and Guttmann Institute on 23 and 24 October in Barcelona, national and international experts shared breakthroughs in the latest neuroregeneration therapies, discussed how to improve prognosis and recovery for spinal-cord injuries and how to optimize the nervous system’s regenerative capacities.

According to Dr. Josep Maria Tormos, scientific leader of this B·Debate meeting of experts and director of research at Institut Guttmann, experimental data in animals shows that it is possible to induce the regeneration of neurons and recover functions lost through injury. Clinical trials are currently being carried out in humans.

More information on the B·Debate website.


B·Debate brought together more than 60 experts in neuroregeneration at CosmoCaixa - Photo: © Biocat, Jordi Cabanas.